Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Prognosis
New breast cancer prognosis research reported from National Cancer Center Hospital East
February 1st, 2007
Investigators publish new data in the report "Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast." According to a study from Kashiwa, Japan, "C-erbB-2 oncogene protein (ErbB-2/HER-2) overexpression is a prognostic marker of breast carcinoma. The purpose of this study was to evaluate serum ErbB-2 for monitoring tumor recurrence of operable breast carcinoma patients." "The subjects were 86 breast carcinoma patients with stage I-IIIB. Sera were collected at preoperative and postoperative periods from 1996 to 2000. The cutoff value was set at 5.4 ng/ml for preoperative patients and at 6.5 ng/ml for postoperative patients. Twenty-nine...
Source: Women's Health Weekly (2007-02-01)
|
